Vivani Medical Files 8-K on Shareholder Votes and Exhibits

TL;DR

Vivani Medical (VANI) filed an 8-K on June 28th covering shareholder votes and financial exhibits.

AI Summary

Vivani Medical, Inc. filed an 8-K on June 28, 2024, reporting on matters submitted to a vote of security holders and financial statements/exhibits. The filing also notes the company's former name was Second Sight Medical Products Inc. and its incorporation state is Delaware.

Why It Matters

This filing provides updates on corporate actions and financial reporting, which are crucial for investors to understand the company's governance and financial health.

Risk Assessment

Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating new or significant risks.

Key Players & Entities

• Vivani Medical, Inc. (company) — Registrant
• Second Sight Medical Products Inc. (company) — Former company name
• June 28, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 1350 S. Loop Road Alameda, California 94502 (address) — Principal executive offices
• (415) 506-8462 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share VANI The Nasdaq Capital M

Filing Documents

• g084314_8k.htm (8-K) — 46KB
• 0001753926-24-001171.txt ( ) — 214KB
• vani-20240628.xsd (EX-101.SCH) — 3KB
• vani-20240628_lab.xml (EX-101.LAB) — 33KB
• vani-20240628_pre.xml (EX-101.PRE) — 22KB
• g084314_8k_htm.xml (XML) — 4KB

07 Submission

Item 5.07 Submission of Matters to a Vote of Security Holders. The 2024 Annual Meeting of Stockholders of Vivani Medical, Inc. ("Vivani" or the "Company") was held on June 27, 2024 (the "Annual Meeting"). Holders of 35,232,561 of 54,978,465 shares of Vivani's common stock were represented at the meeting in person or by proxy, constituting a quorum. The following are the voting results on each matter submitted to the stockholders of Vivani at the Annual Meeting. Proposal 1 : The stockholders elected each of the six director nominees to the Board of Directors of the Company (the "Board") to serve until the 2025 Annual Meeting of Stockholders or until their successors have been duly elected and qualified, as set forth below: Director Name Votes For Votes Withheld Broker Non-Votes Gregg Williams 24,143,432 190,883 10,898,246 Aaron Mendelsohn 24,083,342 250,476 10,898,743 Dean Baker 24,221,582 112,733 10,898,246 Alexandra Larson 24,263,731 70,584 10,898,246 Adam Mendelsohn 24,184,031 150,284 10,898,246 Daniel Bradbury 24,057,281 276,537 10,898,743 Proposal 2 : The stockholders ratified the appointment by the Audit Committee of the Board of BPM LLP as Vivani's independent registered public accounting firm for the fiscal year ending December 31, 2024, as set forth below: Votes For Votes Against Votes Abstained Broker Non-Votes 34,974,648 195,530 62,383 0 Proposal 3 : The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as set forth below: Votes For Votes Against Votes Abstained Broker Non-Votes 22,484,128 203,434 1,646,753 10,898,246

01 Financial

Item 9.01 Financial (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIVANI MEDICAL, INC. Date: June 28, 2024 By: /s/ Adam Mendelsohn Name: Adam Mendelsohn Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR